Otic Pharma, Ltd.

Otic Pharma, Ltd. company information, Employees & Contact Information

Otic Pharma Completes Merger with Tokai Pharmaceuticals Company Renamed Novus Therapeutics, Inc; NASDAQ Ticker "NVUS" IRVINE, Calif., May 10, 2017 /PRNewswire/ -- Otic Pharma, Ltd., a pharmaceutical company focusing on the development of ear, nose, and throat (ENT) products, today announced the close of the previously announced combination with Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI, through May 10, 2017). In connection with the previously announced transaction, Tokai changed its name to Novus Therapeutics, Inc. and effected a 1-for-9 reverse split of its common stock. The common stock is expected to commence trading on a post-reverse split basis upon the opening of trading on May 11, 2017 on the NASDAQ Capital Market under the symbol "NVUS." Read More: http://www.prnewswire.com/news-releases/otic-pharma-completes-merger-with-tokai-pharmaceuticals-300454911.html Novus Therapeutics, Inc. Investor Relations Tel: (949) 238-8090 investors@novustherapeutics.com

Company Details

Founded
-
Address
19900 Macarthur Blvd., Suite 550, Irvine,california 92612,united States
Phone
(949)238-8090
Email
in****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Irvine, California
Looking for a particular Otic Pharma, Ltd. employee's phone or email?

Otic Pharma, Ltd. Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant